Clinical Trial Applications: Filter, Search, and view applications
# | Protocol No | Study Title | Investigator(s) & Site(s) | |
---|---|---|---|---|
101. |
ECCT/14/12/01 | Rivaroxaban for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE) XALIA LEA- Xarelto® for Long-term and Initial Anticoagulation in Venous Thromboembolism… read more |
Principal Investigator(s) 1. Anne Njeri Mugera Njambi Mugera 2. Dr. Martin N Wanyoike Njoroge Wanyoike 3. Charles Muthui Kariuki Muthui Kariuki 4. FEROZ ALI Allibhoy … read more |
View |
102. |
ECCT/13/04/02 | XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (… read more |
Principal Investigator(s) 1. Dr Charles Muthui Kariuki Site(s) in Kenya Nairobi Cardiovascular Clinic |
View |
103. |
ECCT/14/03/02 | Rivaroxaban on prevention of stroke and non-central nervous system systemic embolism in patients with non valvular atrial fibrillation XANTUS-EL, Xarelto on prevention of stroke and non-… read more |
Principal Investigator(s) 1. Warshow Majid Mbarak Site(s) in Kenya 1. MP Shah Hospital (Nairobi City county) |
View |
104. |
ECCT/16/08/02 |
Zeenk study Zeenk Acceptability Study |
Principal Investigator(s) 1. Margaret Oluka 2. David Kimutai 3. Caren Emadu Site(s) in Kenya 1. Mbagathi District Hospital (Nairobi City county) 2.… read more |
View |